Euclidean Capital key facts
- Euclidean Capital is a family office based in New York, New York with 22 tracked portfolio companies.
- Notable positions include ArsenalBio, Neurona Therapeutics, Neo Alternative Asset Managers.
- PrivateMarketView records 1 deal participation by Euclidean Capital.
- The team roster lists 4 people.
About Euclidean Capital
Founded in 2009, Euclidean Capital is a single-family office based at New York, New York. The firm provides financial guidance and asset management services to hedge fund billionaire James Simons.
Investment activity
Euclidean Capital joined 1 recorded round in the last two years. 1 round landed in the last 90 days. Most recently: Savvy (New York) (Series C, Sep 2026).
Euclidean Capital portfolio at a glance
22 portfolio companies are on record for Euclidean Capital, including ArsenalBio, Neurona Therapeutics and Neo Alternative Asset Managers.
19 of the 22 carry a recorded valuation.
Euclidean Capital team
4 people are on record at Euclidean Capital. Senior names include Ashvin Chhabra (Chief Investment Officer), Colin Mackintosh (Executive) and Fred Tencic (Executive). 4 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 22 recorded positions
- ·Watchlist + alerts for Euclidean Capital's activity
Portfolio
22 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| ArsenalBio | — | ▮ | ▮ | ▮ |
| Neurona Therapeutics | Drug Discovery | ▮ | ▮ | ▮ |
| Neo Alternative Asset Managers | — | ▮ | ▮ | ▮ |
+ 19 more companies · all 22, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Euclidean Capital recent deals
1 recordedMembership and data by Private Market View
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Euclidean Capital
- What companies does Euclidean Capital invest in?
- Euclidean Capital has 22 recorded portfolio companies, including ArsenalBio, Neurona Therapeutics, Neo Alternative Asset Managers.
- What is Euclidean Capital's AUM?
- Euclidean Capital manages approximately $780 in assets.